‍🎯 Clairity Raises $43M Series B for AI Breast Cancer Risk Platform‍

Funding will scale its FDA-authorized tool that predicts five-year breast-cancer risk from routine mammograms across U.S. imaging sites.

"We’re proud to stand at the forefront of a paradigm shift – from detection to prevention – and to deliver technology that empowers women and their doctors to predict risk to support action before cancer starts."

— Jeff Luber, CEO of Clairity

🔗 Read More

‍

🌍 Nabta Health Raises $2M Pre-Series A for Hybrid Women’s Health Model‍

Estonia’s Muun develops a real-time biosensor for women’s hormone monitoring.

"For employers and insurers in the region, addressing the women’s health gap is not just a moral imperative; it is a business and productivity one”

— Sophie Smith, Founder and CEO, Nabta Health

🔗 Read More

‍

🦴 Skeletalis Secures $8M to Transform Osteoporosis Treatment for Post-Menopausal Women

The company is developing bone-targeted therapeutics aiming to prevent fractures while avoiding safety issues seen in existing drugs.

🔗 Read More

‍

📈 Sofinnova Partners Closes €650M Capital XI Fund for Early-Stage Healthcare Deals‍

The oversubscribed flagship fund boosts firepower for early-stage biotech and healthtech, including women’s-health innovators in Europe.

"We’re excited to continue backing visionary entrepreneurs and advancing the next wave of breakthroughs in science and medicine"

— Antoine Papiernik, Managing Partner and Chairman of Sofinnova Partners

🔗 Read More

‍

💊 Roche’s Oral Breast-Cancer Pill Delivers Strong Late-Stage Trial Results

Giredestrant, an oral SERD, beat standard endocrine therapy in early-stage HR+ breast cancer, lifting expectations for new oral options.

🔗 Read More

‍

🚀 Fierce Foundry Opens Investment Readiness Bootcamp for Female Founders

The five-week, equity-free programme helps early-stage women founders get investor-ready with expert support on pitch and go-to-market.

🔗 Read More

‍

Another big week! Let us know what you're working on, or who we should feature next.  

‍Email us at info@womenshealthweek.com and put "Scoop Request" as the subject!